Abstract
The Endocannabinoid System (ECS, also known as Endocannabinoidome) plays a key role in the function of the Central Nervous System, though the participation of this system on the early development — specifically in neuroprotection and proliferation of nerve cells — has been poorly studied. Here, we collect and describe evidence regarding how cannabinoid receptors CB1R and CB2R regulate several cell markers related to proliferation. While CB1R participates in the modulation of neuronal and glial proliferation, CB2R is involved in the proliferation of glial cells. The endocannabinoids anandamide (AEA) and 2-arachidonoylglycerol (2-AG) exert significant effects on nerve cell proliferation. AEA generated during embryogenesis induces major effects on the differentiation of neuronal progenitor cells, whereas 2-AG participates in modulating cell migration events rather than affecting the neural proliferation rate. However, although the ECS has been demonstrated to participate in neuroprotection, more characterization on its role in neuronal and glial proliferation and differentiation is needed, especially in brain areas with recognized high neurogenesis rates. This has encouraged scientists to elucidate and propose specific mechanisms related with these cell proliferation mechanisms to better understand some neurodegenerative disorders such as Parkinson, Huntington and Alzheimer diseases, in which neuronal loss and poor neurogenesis are crucial factors for their onset and progression. In this review, we collect and present recent evidence published pointing to an active role of the ECS in the development and proliferation of nerve cells.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Agrawal M, Biswas A (2015) Molecular Diagnostics of Neurodegenerative Disorders Front Mol Biosci 22(2):54. https://doi.org/10.3389/fmolb.2015.00054
Aguado T, Monory K, Palazuelos J, Stella N, Cravatt B, Lutz B, Marsicano G, Kokaia Z, Guzmán M, Galve-Roperh I (2005) The endocannabinoid system drives neural progenitor proliferation. FASEB J 19:1704–1706. https://doi.org/10.1096/fj.05-3995fje
Aguado T, Palazuelos J, Monory K, Stella N, Cravatt B, Lutz B, Mariscano G, Kokaia Z, Guzmán M, Galve-Roperh I (2006) The endocannabinoid system promotes astroglial differentiation by acting on neural progenitor cells. J Neurosci 26:1551–1561. https://doi.org/10.1523/JNEUROSCI.3101-05.2006
Aguado T, Romero E, Monory K, Palazuelos J, Sendtner M, Marsicano G, Lutz B, Guzmán M, Galve-Roperh I (2007) The CB1 receptor mediates excitotoxicity-induced neural progenitor proliferation and neurogenesis. J Biol Chem 282(33):23892–23898. https://doi.org/10.1074/jbc.M700678200
Alexander SP (2012) So what do we call GPR18 now? Br J Pharmacol 165(8):2411–2413. https://doi.org/10.1111/j.1476-5381.2011.01731.x
Alexandre J, Malheiro R, Dias de Silva D, Carmo H, Carvalho F, Silva J (2020) The synthetic cannabinoids THJ-2201 and 5F-PB22 enhance in vitro CB1 receptor-mediated neuronal differentiation at biologically relevant concentrations. Int J Mol Sci 21(17):6277. https://doi.org/10.3390/ijms21176277
Alvarez-Buylla A, Herrera DG, Wichterle H (2000) The subventricular zone: source of neuronal precursors for brain repair. Prog Brain Res 127:1–11. https://doi.org/10.1016/s0079-6123(00)27002-7
Ashton JC, Friberg D, Darlington CL, Smith PF (2006) Expression of the cannabinoid CB2 receptor in the rat cerebellum: an immunohistochemical study. Neurosci Lett 396(2):113–116. https://doi.org/10.1016/j.neulet.2005.11.038
Bacci A, Huguenard J, Prince D (2004) Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids. Nature 431(7006):312–316. https://doi.org/10.1038/nature02913
Benard G, Massa F, Puente N, Lourenco J, Bellocchio L, Soria-Gomez E, Matias I, Delamarre A, Metna-Laurent M, Cannich A, Hebert-Chatelain E, Mulle C, Ortega-Gutiérrez S, Martín-Fontecha M, Klugmann M, Guggenhuber S, Lutz B, Gertsch J, Chaouloff F, López-Rodríguez ML, Grandes P, Rossignol R, Marsicano G (2012) Mitochondrial CB (1) receptors regulate neuronal energy metabolism. Nature Neurosci 15(4):558–564. https://doi.org/10.1038/nn.3053
Berghuis P, Rajnice A, Morozov Y, Ross R, Mulder J, Urban G, Monory K, Marsicano G, Matteoli M, Canty A, Irving A, Katona I, Yanagawa Y, Rakic P, Lutz B, Mackie K, Harkany T (2007) Hardwiring the brain: Endocannabinoid’s shape neuronal connectivity. Sci 316(5828):1212–1216. https://doi.org/10.1126/science.1137406
Biegon A, Kerman I (2001) Autoradiographic study of pre- and postnatal distribution of cannabinoid receptors in human brain. Neuroimage 14(6):1463–1468. https://doi.org/10.1006/nimg.2001.0939.14:1463-1468
Bodor A, Katona I, Nyiri G, Mackie K, Ledent C, Hajos N, Freund TF (2005) Endocannabinoid signaling in rat somatosensory cortex: laminar differences and involvement of specific interneuron types. J Neurosci 25(29):6845–6856. https://doi.org/10.1523/JNEUROSCI.0442-05.2005
Borrelli F, Izzo AA (2009) Role of acylethanolamides in the gastrointestinal tract with special reference to food intake and energy balance. Best Pract Res Clin Endocrinol Metab 23(1):33–49. https://doi.org/10.1016/j.beem.2008.10.003
Bosier B, Lambert DM, Hermans E (2008) Reciprocal influences of CB1 cannabinoid receptor agonists on ERK and JNK signalling in N1E–115 cells. FEBS Lett 582(28):3861–3867. https://doi.org/10.1016/j.febslet.2008.10.022
Buckley NE, Hansson S, Harta G, Mezey E (1998) Expression of the CB1 and CB2 receptor messenger RNAs during embryonic development in the rat. Neuroscience 82(4):1131–1149. https://doi.org/10.1016/s0306-4522(97)00348-5
Campbell WA, Blum S, Reske A, Hoang T, Blackshaw S, Fischer AJ (2021) Cannabinoid signaling promotes the de-differentiation and proliferation of Müller glia-derived progenitor cells. Glia 69(10):2503–2521. https://doi.org/10.1002/glia.24056
Carrier E, Kear CS, Barkmeier AJ, Breese NM, Yang W, Nithipatikom K, Pfister SL, Campbell WB, Hillard CJ (2003) Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonyglycerol, which increases proliferation via a CB2 receptor-dependent mechanism. Mol Pharmacol 65(4):999–1007. https://doi.org/10.1124/mol.65.4.999
Cheyuo C, Aziz M, Wang P (2019) Neurogenesis in neurodegenerative diseases: role of MFG-E8. Front Neurosci 13:569. https://doi.org/10.3389/fnins.2019.00569
Choi ML, Begeti F, Oh JH, Lee SY, O’Keeffe GC, Clelland CD, Tyers P, Cho ZH, Kim YB, Barker RA (2014) Dopaminergic manipulations and its effects on neurogenesis and motor function in a transgenic mouse model of Huntington’s disease. Neurobiol Dis 66:19–27. https://doi.org/10.1016/j.nbd.2014.02.004
Colín-González AL, Paz-Loyola AL, Serratos IN, Seminotti B, Ribeiro CA, Leipnitz G, Souza DO, Wajner M, Santamaría A (2015) The effect of WIN 55,212–2 suggests a cannabinoid-sensitive component in the early toxicity induced by organic acids accumulating in glutaric acidemia type I and in related disorders of propionate metabolism in rat brain synaptosomes. Neuroscience 310:578–588. https://doi.org/10.1016/j.neuroscience.2015.09.043
Cottone E, Pomatto V, Rapelli S, Scandiffio R, Mackie K, Bovolin P (2021) Cannabinoid receptor modulation of neurogenesis: ST14A striatal neural progenitor cells as simplified in vitro model. Molecules 26(5):1448. https://doi.org/10.3390/molecules26051448
de Lahunta A, Glass EN, Kent M (2016) Embryonic development of the central nervous system. Vet Clin North Am Small Anim Pract 46(2):193–216. https://doi.org/10.1016/j.cvsm.2015.10.011
Erkkinen MG, Kim MO, Geschwind MD (2018) Clinical neurology and epidemiology of the major neurodegenerative diseases. Cold Spring Harb Perspect Biol 10:a033118. https://doi.org/10.1101/cshperspect.a033118
Eshghi S, Schaffe DV (2008) Engineering microenvironments to control stem cell fate and function. StemBook Cambridge (MA): Harvard Stem Cell Institute; 2008. PMID: 20614608. https://doi.org/10.3824/stembook.1.5.1
Fedele V, Roybon L, Nordstrom U, Li JY, Brundin P (2011) Neurogenesis in the R6/2 mouse model of Huntington’s disease is impaired at the level of Neuro D1. Neurosci 173:76–81. https://doi.org/10.1016/j.neuroscience.2010.08.022
Fernández-López D, Pradillo JM, García-Yébenes I, Martínez-Orgado JA, Moro MA, Lizasoain I (2010) The cannabinoid WIN55212-2 promotes neural repair after neonatal hypoxia-ischemia. Stroke 41(12):2956–2964. https://doi.org/10.1161/STROKEAHA.110.599357
Fernández-Ruiz J, Berrendero F, Hernández ML, Ramos JA (2000) The endogenous cannabinoid system and brain development. Trends Neurosci 23(1):14–20. https://doi.org/10.1016/s0166-2236(99)01491-5.23:14-20
Fernández-Ruiz J, Gomez M, Hernandez M, de Miguel R, Ramos JA (2004) Cannabinoids and gene expression during brain development. Neurotox Res 6(5):389–401. https://doi.org/10.1007/BF03033314.6:389-401
Freitas HR, Isaac AR, Silva TM, Diniz G, Dos Santos DY, Bockmann EC, Guimarães M, da Costa CK, de Mello FG, Ventura A, de Melo Reis RA, França GR (2019) Cannabinoids induce cell death and promote P2X7 receptor signaling in retinal glial progenitors in culture. Mol Neurobiol 56(9):6472–6486. https://doi.org/10.1007/s12035-019-1537-y
Fride E, Gobshits N, Dahan H, Weller A, Giuffrida A, Ben-Shabat S (2009) The endocannabinoid system during development: emphasis on perinatal events and delayed effects. Vitam Horm 81:139–158. https://doi.org/10.1016/S0083-6729(09)81006-6
Gadadhar A, Marr R, Lazarov O (2011) Presenilin-1 regulates neural progenitor cell differentiation in the adult brain. J Neurosci 31(7):2615–2623. https://doi.org/10.1523/JNEUROSCI.4767-10.2011
Gakhar-Koppole N, Hundeshagen P, Mandl C, Weyer SW, Allinquant B, Müller U, Ciccolini F (2008) Activity requires soluble amyloid precursor protein alpha to promote neurite outgrowth in neural stem cell-derived neurons via activation of the MAPK pathway. Eur J Neurosci 28(5):871–882. https://doi.org/10.1111/j.1460-9568.2008.06398.x
Galve-Roperh I, Aguado T, Palazuelos J, Guzmán M (2007) The endocannabinoid system and neurogenesis in health and disease. The Neuroscientist: a Review Journal Bringing Neurobiology, Neurology and Psychiatry 13(2):109–114. https://doi.org/10.1177/1073858406296407
Galve-Roperh I, Aguado T, Rueda D, Velasco G, Guzmán M (2006) Endocannabinoids: a new family of lipid mediators involved in the regulation of neural cell development. Curr Pharm Des 12(18):2319–2325. https://doi.org/10.2174/138161206777585139
Galve-Roperh I, Chiurchiù V, Díaz-Alonso J, Bari M, Guzmán M, Maccarrone M (2013) Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation. Prog Lipid Res 52(4):633–650. https://doi.org/10.1016/j.plipres.2013.05.004
Gao P, Postiglione MP, Krieger TG, Hernandez L, Wang C, Han Z, Streicher C, Papusheva E, Insolera R, Chugh K, Kodish O, Huang K, Simons BD, Luo L, Hippenmeyer S, Shi SH (2014) Deterministic progenitor behavior and unitary production of neurons in the neocortex. Cell 159(4):775–788. https://doi.org/10.1016/j.cell.2014.10.027
Gao Z, Ure K, Ables JL, Lagace DC, Nave KA, Goebbels S, Eisch AJ, Hsieh J (2009) Neurod1 is essential for the survival and maturation of adult-born neurons. Nat Neurosci 12(9):1090–1092. https://doi.org/10.1038/nn.2385
Garcia-Arencibia M, Molina-Holgado E, Molina-Holgado F (2019) Effect of endocannabinoid signalling on cell fate: life, death, differentiation and proliferation of brain cells. Br J Pharmacol 176(10):1361–1369. https://doi.org/10.1111/bph.14369
Gomez O, Arevalo-Martin A, Garcia-Ovejero D, Ortega-Gutierrez S, Cisneros JA, Almazan G, Sánchez-Rodriguez MA, Molina-Holgado F, Molina-Holgado E (2010) The constitutive production of the endocannabinoid 2-arachidonoylglycerol participates in oligodendrocyte differentiation. Glia 16:1913–1927. https://doi.org/10.1002/glia.21061
Gómez-López S, Lerner RG, Petritsch C (2014) Asymmetric cell division of stem and progenitor cells during homeostasis and cancer. Cell Mol Life Sci 71(4):575–597. https://doi.org/10.1007/s00018-013-1386-1
Harkany T, Guzmán M, Galve-Roperh I, Berghuis P, Devi LA, Mackie K (2007) The emerging functions of endocannabinoid signaling during CNS development. Trends Pharmacol Sci 28(2):83–92. https://doi.org/10.1016/j.tips.2006.12.004
Hill JD, Zuluaga-Ramirez V, Gajghate S, Winfield M, Persidsky Y (2018) Activation of GPR55 increases neural stem cell proliferation and promotes early adult hippocampal neurogenesis. Br J Pharmacol 175(16):3407–3421. https://doi.org/10.1111/bph.14387
Höglinger GU, Rizk P, Muriel MP, Duyckaerts C, Oertel WH, Caille I, Hirsch EC (2004) Dopamine depletion impairs precursor cell proliferation in Parkinson disease. Nat Neurosci 7(7):726–735. https://doi.org/10.1038/nn1265
Homem CC, Repic M, Knoblich JA (2015) Proliferation control in neural stem and progenitor cells. Nat Rev Neurosci 16(11):647–659. https://doi.org/10.1038/nrn4021
Horgusluoglu E, Nudelman K, Nho K, Saykin AJ (2017) Adult neurogenesis and neurodegenerative diseases: a systems biology perspective. American journal of medical genetics. Part b, Neuropsychiatric Genetics: the Official Publication of the International Society of Psychiatric Genetics 174:93–112. https://doi.org/10.1002/ajmg.b.32429
Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG (2002) International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors Pharmacol Rev 54:161–202. https://doi.org/10.1124/pr.54.2.161
Iannotti FA, Vitale RM (2021) The endocannabinoid system and PPARs: focus on their signalling crosstalk, action and transcriptional regulation. Cells 10(3):586. https://doi.org/10.3390/cells10030586
Iwakura Y, Piao YS, Mizuno M, Takei N, Kakita A, Takahashi H, Nawa H (2005) Influences of dopaminergic lesion on epidermal growth factor-ErbB signals in Parkinson’s disease and its model: neurotrophic implication in nigrostriatal neurons. J Neurochem 93(4):974–983. https://doi.org/10.1111/j.1471-4159.2005.03073.x
Janssens DH, Komori H, Grbac D, Chen K, Koe CT, Wang H, Lee CY (2014) Earmuff restricts progenitor cell potential by attenuating the competence to respond to self-renewal factors. Development 141(5):1036–1046. https://doi.org/10.1242/dev.106534
Jiang W, Zhang Y, Xiao L, Van Cleemput J, Ji SP, Bai G, Zhang X (2005) Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects. J Clin Invest 115(11):3104–3116. https://doi.org/10.1172/JCI25509
Jimenez-Blasco D, Busquets-Garcia A, Hebert-Chatelain E, Serrat R, Vicente-Gutierrez C, Ioannidou C, Gómez-Sotres P, Lopez-Fabuel I, Resch-Beusher M, Resel E, Arnouil D, Saraswat D, Varilh M, Cannich A, Julio-Kalajzic F, Bonilla-Del Río I, Almeida A, Puente N, Achicallende S, Lopez-Rodriguez ML, Marsicano G (2020) Glucose metabolism links astroglial mitochondria to cannabinoid effects. Nature 583(7817):603–608. https://doi.org/10.1038/s41586-020-2470-y
Kandasamy M, Couillard-Despres S, Raber KA, Stephan M, Lehner B, Winner B, Kohl Z, Rivera FJ, Nguyen HP, Riess O, Bogdahn U, Winkler J, von Horsten S, Aigner L (2010) Stem cell quiescence in the hippocampal neurogenic niche is associated with elevated transforming growth factor-beta signaling in an animal model of Huntington disease. J Neuropathol Exp Neurol 69(7):717–728. https://doi.org/10.1097/NEN.0b013e3181e4f733
Kreitzer AC, Carter AG, Regehr WG (2002) Inhibition of interneuron firing extends the spread of endocannabinoid signaling in the cerebellum. Neuron 34(5):787–796. https://doi.org/10.1016/s0896-6273(02)00695-5
Kuhn HG, Winkler J, Kempermann G, Thal LJ, Gage FH (1997) Epidermal growth factor and fibroblast growth factor-2 have different effects on neural progenitors in the adult rat brain. J Neurosci 17(15):5820–5829. https://doi.org/10.1523/JNEUROSCI.17-15-05820.1997
Lacar B, Young SZ, Platel JC, Bordey A (2010) Imaging and recording subventricular zone progenitor cells in live tissue of postnatal mice. Front Neurosci 4:43. https://doi.org/10.3389/fnins.2010.00043
Liu X, Bolteus AJ, Balkin DM, Henschel O, Bordey A (2006) GFAP-expressing cells in the postnatal subventricular zone display a unique glial phenotype intermediate between radial glia and astrocytes. Glia 54(5):394–410. https://doi.org/10.1002/glia.20392
López-Rodríguez ML, Viso A, Ortega-Gutiérrez S, Díaz-Laviada I (2005) Involvement of cannabinoids in cellular proliferation. Mini Rev Med Chem 5(1):97–106. https://doi.org/10.2174/1389557053402819
Low VF, Dragunow M, Tippett LJ, Faull RL, Curtis MA (2011) No change in progenitor cell proliferation in the hippocampus in Huntington’s disease. Neuroscience 199:577–588. https://doi.org/10.1016/j.neuroscience.2011.09.010
Lu HC, Mackie K (2021) Review of the endocannabinoid system. Biol Psychiatry Cogn Neurosci Neuroimaging 6(6):607–615. https://doi.org/10.1016/j.bpsc.2020.07.016
Maccarrone M, Guzmán M, Mackie K, Doherty P, Harkany T (2014) Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies. Nat Rev Neurosci 15(12):786–801. https://doi.org/10.1038/nrn3846
Marichal-Cancino BA, Fajardo-Valdez A, Ruiz-Contreras AE, Mendez-Díaz M, Prospero-García O (2017) Advances in the physiology of GPR55 in the Central Nervous System. Curr Neuropharmacol 15(5):771–778. https://doi.org/10.2174/1570159X14666160729155441
Maroso M, Szabo GG, Kim HK, Alexander A, Bui AD, Lee SH, Lutz B, Soltesz I (2016) Cannabinoid control of learning and memory through HCN channels. Neuron 89(5):1059–1073. https://doi.org/10.1016/j.neuron.2016.01.023
Mato S, Del Olmo E, Pazos A (2003) Ontogenetic development of cannabinoid receptor expression and signal transduction functionality in the human brain. Eur J Neurosci 17(9):1747–1754. https://doi.org/10.1046/j.1460-9568.2003.02599.x
Maya-López M, Colín-González AL, Aguilera G, de Lima ME, Colpo-Ceolin A, Rangel-López E, Villeda-Hernández J, Rembao-Bojórquez D, Túnez I, Luna-López A, Lazzarini-Lechuga R, González-Puertos VY, Posadas-Rodríguez P, Silva-Palacios A, Königsberg M, Santamaría A (2017) Neuroprotective effect of WIN55,212–2 against 3-nitropropionic acid-induced toxicity in the rat brain: involvement of CB1 and NMDA receptors. Am J Transl Res 9(2):261–274. eCollection 2017 9:261–274
Mechoulam R, Parker LA (2013) The endocannabinoid system and the brain. Annu Rev Psychol 64:21–47. https://doi.org/10.1146/annurev-psych-113011-143739
Ming GL, Song H (2011) Adult neurogenesis in the mammalian brain: significant answers and significant questions. Neuron 70(4):687–702. https://doi.org/10.1016/j.neuron.2011.05.001
Molina-Holgado E, Vela JM, Arévalo-Martín A, Almazán G, Molina-Holgado F, Borrell J, Guaza C (2002) Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling. J Neurosci 22:9742–9753. https://doi.org/10.1523/JNEUROSCI.22-22-09742.2002
Molina-Holgado F, Rubio-Araiz A, García-Ovejero D, Williams RJ, Moore JD, Arévalo-Martín A, Gómez-Torres O, Molina-Holgado E (2007) CB2 cannabinoid receptors promote mouse neural stem cell proliferation. Eur J Neurosci 25(3):629–634. https://doi.org/10.1111/j.1460-9568.2007.05322.x
Mu Y, Gage FH (2011) Adult hippocampal neurogenesis and its role in Alzheimer’s disease. Mol Neurodegener 6:85. https://doi.org/10.1186/1750-1326-6-85
Mücke M, Carter C, Cuhls H, Prüß M, Radbruch L, Häuser W (2016) Cannabinoide in der palliativen Versorgung: Systematische Übersicht und Metaanalyse der Wirksamkeit, Verträglichkeit und Sicherheit [Cannabinoids in palliative care: systematic review and meta-analysis of efficacy, tolerability and safety]. Schmerz 30:25–36. German. https://doi.org/10.1007/s00482-015-0085-2
Mulder J, Aguado T, Keimpema E, Barabás K, Ballester Rosado CJ, Nguyen L, Monory K, Marsicano G, Di Marzo V, Hurd YL, Guillemot F, Mackie K, Lutz B, Guzmán M, Lu HC, Galve-Roperh I, Harkany T (2008) Endocannabinoid signaling controls pyramidal cell specification and long-range axon patterning. Proc Natl Acad Sci USA 24;105(25):8760–5. https://doi.org/10.1073/pnas.0803545105
Núñez E, Benito C, Pazos MR, Barbachano A, Fajardo O, González S, Tolón RM, Romero J (2004) Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: an immunohistochemical study. Synapse 53(4):208–213. https://doi.org/10.1002/syn.20050
Oka S, Nakajima K, Yamashita A, Kishimoto S, Sugiura T (2007) Identification of GPR55 as a lysophosphatidylinositol receptor. Biochem Biophys Res Commun 362(4):928–934. https://doi.org/10.1016/j.bbrc.2007.08.078
Onaivi ES, Ishiguro H, Gong JP, Patel S, Meozzi PA, Myers L, Perchuk A, Mora Z, Tagliaferro PA, Gardner E, Brusco A, Akinshola BE, Liu QR, Chirwa SS, Hope B, Lujilde J, Inada T, Iwasaki S, Macharia D, Teasenfitz L, Arinami T, Uhl GR (2008) Functional expression of brain neuronal CB2 cannabinoid receptors are involved in the effects of drugs of abuse and in depression. Ann NY Acad Sci 1139:434–449. https://doi.org/10.1196/annals.1432.036
Oudin MJ, Gajendra S, Williams G, Hobbs C, Lalli G, Doherty P (2011) Endocannabinoids regulate the migration of subventricular zone-derived neuroblasts in the postnatal brain. J Neurosci 31(11):4000–4011. https://doi.org/10.1523/JNEUROSCI.5483-10.2011
Palazuelos J, Aguado T, Egia A, Mechoulam R, Guzmán M, Galve-Roperh I (2006) Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation. FASEB J 20(13):2405–2407. https://doi.org/10.1096/fj.06-6164fje
Palazuelos J, Ortega Z, Díaz-Alonso J, Guzmán M, Galve-Roperh I (2012) CB2 cannabinoid receptors promote neural progenitor cell proliferation via mTORC1 signaling. J Biol Chem 287(2):1198–1209. https://doi.org/10.1074/jbc.M111.291294
Paria BC, Dey SK (2000) Ligand-receptor signaling with endocannabinoids in preimplantation embryo development and implantation. Chem Phys Lipids 108(1–2):211–220. https://doi.org/10.1016/s0009-3084(00)00197-3
Phillips W, Morton AJ, Barker RA (2005) Abnormalities of neurogenesis in the R6/2 mouse model of Huntington’s disease are attributable to the in vivo microenvironment. J Neurosci 25(50):11564–11576. https://doi.org/10.1523/JNEUROSCI.3796-05.2005
Ramírez-Orozco RE, García-Ruiz R, Morales P, Villalón CM, Villafán-Bernal JR, Marichal-Cancino BA (2019) Potential metabolic and behavioural roles of the putative endocannabinoid receptors GPR18, GPR55 and GPR119 in feeding. Curr Neuropharmacol 17(10):947–960. https://doi.org/10.2174/1570159X17666190118143014
Rangel-López E, Colín-González AL, Paz-Loyola AL, Pinzón E, Torres I, Serratos IN, Castellanos P, Wajner M, Souza DO, Santamaría A (2015) Cannabinoid receptor agonists reduce the short-term mitochondrial dysfunction and oxidative stress linked to excitotoxicity in the rat brain. Neuroscience 285:97–106. https://doi.org/10.1016/j.neuroscience.2014.11.016
Rivera P, Silva-Peña D, Blanco E, Vargas A, Arrabal S, Serrano A, Pavón FJ, Bindila L, Lutz B, Rodríguez de Fonseca F, Suárez J (2019) Oleoylethanolamide restores alcohol-induced inhibition of neuronal proliferation and microglial activity in striatum. Neuropharmacology 146:184–197. https://doi.org/10.1016/j.neuropharm.2018.11.037.146:184-197
Romero J, Garcia-Palomero E, Berrendero F, Garcia-Gil L, Hernandez ML, Ramos JA, Fernández-Ruiz JJ (1997) Atypical location of cannabinoid receptors in white matter areas during rat brain development. Synapse 26(3):317–323. https://doi.org/10.1002/(SICI)1098-2396(199707)26:3%3c317::AID-SYN12%3e3.0.CO;2-S.e26:317-323
Sánchez-Pastor E, Andrade F, Sánchez-Pastor JM, Elizalde A, Huerta M, Virgen-Ortiz A, Trujillo X, Rodríguez-Hernández A (2014) Cannabinoid receptor type 1 activation by arachidonylcyclopropylamide in rat aortic rings causes vasorelaxation involving calcium-activated potassium channel subunit alpha-1 and calcium channel, voltage-dependent, L type, alpha 1C subunit. Eur J Pharmacol 729:100–106. https://doi.org/10.1016/j.ejphar.2014.02.016
Shinjyo N, Piscitelli F, Verde R, Di Marzo V (2013) Impact of omega-6 polyunsaturated fatty acid supplementation and γ-aminobutyric acid on astrogliogenesis through the endocannabinoid system. J Neurosci Res 91(7):943–953. https://doi.org/10.1002/jnr.23231
Singh R, Munakomi S (2022) Embryology, Neural Tube. [Updated 2022 May 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 https://www.ncbi.nlm.nih.gov/books/NBK542285/
Smith A, Kaufman F, Sandy MS, Cardenas A (2020) Cannabis exposure during critical windows of development: epigenetic and molecular pathways implicated in neuropsychiatric disease. Curr Environ Health Rep 7(3):325–342. https://doi.org/10.1007/s40572-020-00275-4
Soltys J, Yushak M, Mao-Draayer Y (2010) Regulation of neural progenitor cell fate by anandamide. Biochem Biophys Res Commun 400(1):21–26. https://doi.org/10.1016/j.bbrc.2010.07.129
Stella N (2004) Cannabinoid signaling in glial cells. Glia 48(4):267–277. https://doi.org/10.1002/glia.20084
Sun J, Fang YQ, Ren H, Chen T, Guo JJ, Yan J, Song S, Zhang LY, Liao H (2013) WIN55,212–2 protects oligodendrocyte precursor cells in stroke penumbra following permanent focal cerebral ischemia in rats. Acta Pharmacol Sin 34(1):119–128. https://doi.org/10.1038/aps.2012.141
Tao R, Huang S, Zhou J, Ye L, Shen X, Wu J, Qian L (2022) Neonatal supplementation of oleamide during suckling promotes learning ability and memory in adolescent mice. J Nutr 152(3):889–898. https://doi.org/10.1093/jn/nxab442
Trazzi S, Steger M, Mitrugno VM, Bartesaghi R, Ciani E (2010) CB1 cannabinoid receptors increase neuronal precursor proliferation through Akt/glycogen synthase kinase-3beta/beta-catenin signaling. J Biol Chem 285(13):10098–10109. https://doi.org/10.1074/jbc.M109.043711
Van den Berge SA, van Strien ME, Korecka JA, Dijkstra AA, Sluijs JA, Kooijman L, Eggers R, De Filippis L, Vescovi AL, Verhaagen J, van de Berg WD, Hol EM (2011) The proliferative capacity of the subventricular zone is maintained in the parkinsonian brain. Brain 134(Pt 11):3249–3263. https://doi.org/10.1093/brain/awr256
Van Sickle MD, Duncan M, Kingsley PJ, Mouihate A, Urbani P, Mackie K, Stella N, Makriyannis A, Piomelli D, Davison JS, Marnett LJ, Di Marzo V, Pittman QJ, Patel KD, Sharkey KA (2005) Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 310(5746):329–332. https://doi.org/10.1126/science.1115740
Vannacci A, Giannini L, Masini E, Mannaioni PF (2003) Cannabinoid-induced activation of ERK and AKT in mast cells may be mediated by intracellular NO production. J Immunol 171(6):2767. https://doi.org/10.4049/jimmunol.171.6.2767-a
Voigt T (1989) Development of glial cells in the cerebral wall of ferrets: direct tracing of their transformation from radial glia into astrocytes. J Comp Neurol 289(1):74–88. https://doi.org/10.1002/cne.902890106
Winner B, Couillard-Despres S, Geyer M, Aigner R, Bogdahn U, Aigner L, Kuhn HG, Winkler J (2008) Dopaminergic lesion enhances growth factor-induced striatal neuroblast migration. J Neuropathol Exp Neurol 67(2):105–116. https://doi.org/10.1097/nen.0b013e3181630cff
Winner B, Winkler J (2015) Adult neurogenesis in neurodegenerative diseases. Cold Spring Harb Perspect Biol 7(4):a021287. https://doi.org/10.1101/cshperspect.a021287
Wolf SA, Bick-Sander A, Fabel K, Leal-Galicia P, Tauber S, Ramirez-Rodriguez G, Müller A, Melnik A, Waltinger TP, Ullrich O, Kempermann G (2010) Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis. Cell Commun Signal 8:12. https://doi.org/10.1186/1478-811X-8-12
Xapelli S, Agasse F, Grade S, Bernardino L, Ribeiro FF, Schitine CS, Heimann AS, Ferro ES, Sebastião AM, De Melo Reis RA, Malva JO (2014) Modulation of subventricular zone oligodendrogenesis: a role for hemopressin? Front Cell Neurosci 8:59. https://doi.org/10.3389/fncel.2014.00059
Xapelli S, Agasse F, Sardà-Arroyo L, Bernardino L, Santos T, Ribeiro FF, Valero J, Bragança J, Schitine C, de Melo Reis RA, Sebastião AM, Malva JO (2013) Activation of type 1 cannabinoid receptor (CB1R) promotes neurogenesis in murine subventricular zone cell cultures. PLoS ONE 8(5):e63529. https://doi.org/10.1371/journal.pone.0063529
Yanes C, Monzon-Mayor M, Ghandour MS, de Barry J, Gombos G (1990) Radial glia and astrocytes in developing and adult telencephalon of the lizard Gallotia galloti as revealed by immunohistochemistry with anti-GFAP and anti-vimentin antibodies. J Comp Neurol 295(4):559–568. https://doi.org/10.1002/cne.902950405
Zimmermann T, Maroso M, Beer A, Baddenhausen S, Ludewig S, Fan W, Vennin C, Loch S, Berninger B, Hofmann C, Korte M, Soltesz I, Lutz B, Leschik J (2018) Neural stem cell lineage-specific cannabinoid type-1 receptor regulates neurogenesis and plasticity in the adult mouse hippocampus. Cereb Cortex 28(12):4454–4471. https://doi.org/10.1093/cercor/bhy258
Funding
This work was partially funded by the Consejo Nacional de Ciencia y Tecnología (CONACyT, Mexico) through the scholarship 2021–000001-01NACF-03208. The sponsor was not involved in design, collection, analysis or interpretation of data, neither in writing of the report or decision to submit the article for publication.
Author information
Authors and Affiliations
Contributions
Conceptualization ER-L, HAR-C, AS; Investigation HAR-C, BR-B, LS-C, MGA-M; Data depuration BR-B, LS-C; Writing/Original draft preparation HAR-C, ER-L, AS; Formal analysis HAR-C, BR-B, LS-C; Writing/Review and editing ER-L, AS.; Supervision ER-L. All authors have read and agreed to the published version of the manuscript.
Corresponding authors
Ethics declarations
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Ruiz-Contreras, H.A., Santamaría, A., Arellano-Mendoza, M.G. et al. Modulatory Activity of the Endocannabinoid System in the Development and Proliferation of Cells in the CNS. Neurotox Res 40, 1690–1706 (2022). https://doi.org/10.1007/s12640-022-00592-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12640-022-00592-6